INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2015 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Invivo Therapeutics Holdings Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2015 to Q3 2023.
Invivo Therapeutics Holdings Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $38K, a 2.7% increase year-over-year.
Invivo Therapeutics Holdings Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $187K, a 3.11% decline year-over-year.
Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2022 was $159K, a 49.5% decline from 2021.
Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2021 was $315K, a 46.5% increase from 2020.
Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2020 was $215K, a 19.8% decline from 2019.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	$187K	$38K	+$1K	+2.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$186K	$38K	+$21K	+124%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$165K	$62K	+$6K	+10.7%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$159K	$49K	-$34K	-41%	Oct 1, 2022	Dec 31, 2022	10-K	2023-03-01
Q3 2022	$193K	$37K	-$48K	-56.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	$241K	$17K	-$78K	-82.1%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	$319K	$56K	+$4K	+7.69%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-12
Q4 2021	$315K	$83K	+$39K	+88.6%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-01
Q3 2021	$276K	$85K	+$29K	+51.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-07
Q2 2021	$247K	$95K	+$50K	+111%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08
Q1 2021	$197K	$52K	-$18K	-25.7%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$215K	$44K	-$21K	-32.3%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-07
Q3 2020	$236K	$56K	-$12K	-17.6%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$248K	$45K	-$23K	-33.8%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020	$271K	$70K	+$3K	+4.48%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q4 2019	$268K	$65K	-$12K	-15.6%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-01
Q3 2019	$280K	$68K	-$17K	-20%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-06
Q2 2019	$297K	$68K	-$82K	-54.7%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-11
Q1 2019	$379K	$67K	-$239K	-78.1%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-13
Q4 2018	$618K	$77K	-$408K	-84.1%	Oct 1, 2018	Dec 31, 2018	10-K	2020-02-20
Q3 2018	$1.03M	$85K	-$915K	-91.5%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	$1.94M	$150K	-$1.15M	-88.5%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018	$3.09M	$306K	-$1.01M	-76.7%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q4 2017	$4.1M	$485K	-$978K	-66.8%	Oct 1, 2017	Dec 31, 2017	10-K	2019-04-01
Q3 2017	$5.08M	$1M	-$200K	-16.7%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-08
Q2 2017	$5.28M	$1.3M	+$100K	+8.33%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-07
Q1 2017	$5.18M	$1.32M	+$115K	+9.58%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-07
Q4 2016	$5.06M	$1.46M			Oct 1, 2016	Dec 31, 2016	10-K	2018-03-12
Q3 2016		$1.2M	-$172K	-12.5%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-30
Q2 2016		$1.2M			Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-08
Q1 2016		$1.2M			Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-04
Q3 2015		$1.37M			Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-04

* An asterisk sign (*) next to the value indicates that the value is likely invalid.